Bausch Health Companies Inc. (BHC)

6.43 -0.18 (-2.72%)

As of 2025-10-30 18:30:31 EST

Bausch Health Companies Inc. (formerly Valeant and ICN Pharmaceuticals) is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.

Traded asNYSE: BHC
ISINCA0717341071
CIK0000885590
LEIB3BS7ACMDUWISF18KY76
EIN—
SectorPharmaceuticals
IndustryPharmaceutical Preparations
CEOThomas J. Appio
Employees7,000
Fiscal Year End1231
Address2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8
Phone514-744-6792
Websitehttp://bauschhealth.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
BHCBausch Health Companies Inc.2025-10-30 18:30:316.43-0.18-2.72
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
BHC0000885590Bausch Health Companies Inc.CA0717341071B3BS7ACMDUWISF18KY76—NYSE2834Pharmaceutical Preparations1231NJ2150 ST. ELZEAR BLVD. WESTQUEBECA8H7L 4A8CANADACA514-744-67922150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A82150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8Valeant Pharmaceuticals International, Inc.Pharmaceuticals1959Thomas J. Appio7,000http://bauschhealth.com2,125,737,497370,473,221370,516,926Bausch Health Companies Inc. (formerly Valeant and ICN Pharmaceuticals) is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.2025-10-30 13:54:40
This is a preview of the latest data. Subscribe to access the full data.
BHC Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
BHC Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20242,125,737,497-292,820,831-12.1072367,933,8972,521,9440.6902
20232,418,558,328-88,563,889-3.5325365,411,9533,374,7620.9322
20222,507,122,217-6,206,591,701-71.2279362,037,1912,390,6950.6647
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Seana CarsonExecutive Vice President, General Counsel2024579,67002,950,720433,1508,9393,972,479
Aimee J. LenarExecutive Vice President2024300,000400,0001,056,657227,5302,2501,986,437
Thomas J. AppioChief Executive Officer20241,226,308013,141,5741,854,00017,25116,239,133
Jean-Jaques CharhonChief Financial Officer, Executive Vice President2024255,769300,0003,526,288185,03004,267,087
John S. BarresiChief Financial Officer, Controller, Chief Accounting Officer, Senior Vice President2024553,15450,0001,007,639337,80026,5251,975,118
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202420,700
202320,270
202219,900
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue9,625,000,0008,757,000,0008,124,000,000
Cost Of Revenue2,729,000,0002,519,000,0002,336,000,000
Gross Profit———
Research And Development Expenses616,000,000604,000,000529,000,000
General And Administrative Expenses3,296,000,0002,917,000,0002,625,000,000
Operating Expenses8,079,000,0007,794,000,0007,670,000,000
Operating Income1,546,000,000963,000,000454,000,000
Net Income-46,000,000-592,000,000-225,000,000
Earnings Per Share Basic-0.13-1.62-0.62
Earnings Per Share Diluted-0.13-1.62-0.62
Weighted Average Shares Outstanding Basic368,000,000364,900,000362,000,000
Weighted Average Shares Outstanding Diluted368,000,000364,900,000362,000,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents1,181,000,000947,000,000564,000,000
Marketable Securities Current———
Accounts Receivable2,140,000,0001,998,000,0001,790,000,000
Inventories1,595,000,0001,544,000,0001,090,000,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current5,774,000,0005,596,000,0004,247,000,000
Marketable Securities Non Current———
Property Plant And Equipment1,780,000,0001,707,000,0001,600,000,000
Other Assets Non Current363,000,000307,000,000326,000,000
Total Assets Non Current1,780,000,0001,707,000,0001,600,000,000
Total Assets26,523,000,00027,350,000,00025,686,000,000
Accounts Payable656,000,000719,000,000521,000,000
Deferred Revenue———
Short Term Debt2,674,000,000450,000,000432,000,000
Other Liabilities Current3,422,000,0003,133,000,0002,988,000,000
Total Liabilities Current6,752,000,0004,302,000,0003,941,000,000
Long Term Debt21,616,000,00022,388,000,00020,766,000,000
Other Liabilities Non Current713,000,000776,000,000741,000,000
Total Liabilities Non Current20,093,000,00023,130,000,00021,485,000,000
Total Liabilities26,845,000,00027,432,000,00025,426,000,000
Common Stock10,490,000,00010,423,000,00010,391,000,000
Retained Earnings-9,824,000,000-9,778,000,000-9,186,000,000
Accumulated Other Comprehensive Income-2,179,000,000-1,881,000,000-2,056,000,000
Total Shareholders Equity-1,279,000,000-1,022,000,000-692,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization1,267,000,0001,264,000,0001,394,000,000
Share Based Compensation Expense150,000,000132,000,000126,000,000
Other Non Cash Income Expense———
Change In Accounts Receivable216,000,000195,000,00057,000,000
Change In Inventories267,000,000322,000,000198,000,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable357,000,000158,000,000-75,000,000
Change In Other Liabilities———
Cash From Operating Activities1,597,000,0001,032,000,000-728,000,000
Purchases Of Marketable Securities12,000,00027,000,00017,000,000
Sales Of Marketable Securities14,000,00026,000,00022,000,000
Acquisition Of Property Plant And Equipment337,000,000215,000,000220,000,000
Acquisition Of Business—1,890,000,00045,000,000
Other Investing Activities———
Cash From Investing Activities-454,000,000-2,145,000,000-303,000,000
Tax Withholding For Share Based Compensation26,000,00024,000,00031,000,000
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt661,000,0003,291,000,0006,836,000,000
Repayment Of Long Term Debt1,460,000,0001,710,000,0007,846,000,000
Other Financing Activities-11,000,000-11,000,000-11,000,000
Cash From Financing Activities-868,000,0001,475,000,000-474,000,000
Change In Cash239,000,000371,000,000-1,528,000,000
Cash At End Of Period1,181,000,000947,000,000564,000,000
Income Taxes Paid61,000,000237,000,000266,000,000
Interest Paid1,674,000,0001,533,000,0001,540,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-0.13-1.62-0.62
Price To Earnings Ratio-62-4.9506-10.129
Earnings Growth Rate-91.9753161.2903-76.5152
Price Earnings To Growth Ratio0.6741-0.03070.1324
Book Value Per Share-0.875-0.22470.7182
Price To Book Ratio-9.2114-35.6898.7437
Ebitda2,670,000,0002,237,000,0002,899,000,000
Enterprise Value26,075,080,00024,817,498,00022,907,360,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio-18.9914-22.3464-30.6329
Capital Expenditures1,340,000,0001,371,000,0001,396,000,000
Free Cash Flow257,000,000-339,000,000-2,124,000,000
Return On Equity0.0360.57930.3251
One Year Beta0.93571.69781.4013
Three Year Beta1.38381.40541.3465
Five Year Beta1.34471.36851.3644
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
WECHSLER AMY BDirector2025-09-301,065A265,452
LEUNG SANDRADirector2025-09-303,673A33,822
Paulson JohnDirector2025-09-309,689A351,128
Carson SeanaEVP, General Counsel2025-09-0813,370D499,585
Carson SeanaEVP, General Counsel2025-09-0551,337D512,955
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Susie Lee2020-10-07NV03Sale2020-08-27Joint$1,001 - $15,000
Susie Lee2020-04-28NV03Purchase2020-02-24Joint$1,001 - $15,000
Susie Lee2020-02-25NV03Purchase2020-01-06Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Inspire Advisors, LLC2025-09-30261,58040,5556.45
Glass Jacobson Investment Advisors llc2025-09-302,4003726.4516
Sequoia Financial Advisors, LLC2025-09-30129,00020,0006.45
Sequoia Financial Advisors, LLC2025-09-30155,82024,1586.45
BFSG, LLC2025-09-3093,30014,4656.4501
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
AMERICAN CENTURY ETF TRUST2025-08-31G ClassAVDNX3,52026,040.850.0063
AMERICAN CENTURY ETF TRUST2025-08-31Institutional ClassAVDEX3,52026,040.850.0063
VANGUARD WORLD FUND2025-08-31ETF SharesVSGX53,205393,608.910.0078
iSHARES TRUST2025-08-31iShares MSCI World Small-Cap ETFWSML21,875161,830.560.0219
SCHWAB STRATEGIC TRUST2025-08-31Schwab International Small-Cap Equity ETFSCHC543,9124,025,016.150.084
This is a preview of the latest data. Subscribe to access the full data.